Author

Jesús M. Bañales

Applications of organoids in liver diseases
Applications of organoids in liver diseases

Jesús M. Bañales

Cholangiocarcinoma landscape in Europe: Updates from the European Registry
Cholangiocarcinoma landscape in Europe: Updates from the European Registry

Jesús M. Bañales

Biomarkers of liver disease
Biomarkers of liver disease

Jesús M. Bañales  et al.

LIVER MIRNA-222-3P IS ACTIVATED IN NON-ALCOHOLIC STEATOHEPATITIS AND ABLATION PREVENTS DISEASE PATHOGENESIS
LIVER MIRNA-222-3P IS ACTIVATED IN NON-ALCOHOLIC STEATOHEPATITIS AND ABLATION PREVENTS DISEASE PATHOGENESIS

Jesús M. Bañales  et al.

EXTRACELLULAR VESICLES FROM TGR5-ACTIVATED ADIPOCYTES ELICIT ANTI-INFLAMMATORY EFFECTS UPON HEPATOCYTES EXPOSED TO NAFLD-ASSOCIATED PATHOGENIC STIMULI
EXTRACELLULAR VESICLES FROM TGR5-ACTIVATED ADIPOCYTES ELICIT ANTI-INFLAMMATORY EFFECTS UPON HEPATOCYTES EXPOSED TO NAFLD-ASSOCIATED PATHOGENIC STIMULI

Jesús M. Bañales  et al.

NOVEL PLATINUM-BASED CHEMOTHERAPEUTIC AGENTS HALT CHOLANGIOCARCINOMA PROGRESSION THROUGH THE INDUCTION OF DOUBLE-STRAND DNA BREAKS, PREVENTING DNA REPAIR MECHANISMS
NOVEL PLATINUM-BASED CHEMOTHERAPEUTIC AGENTS HALT CHOLANGIOCARCINOMA PROGRESSION THROUGH THE INDUCTION OF DOUBLE-STRAND DNA BREAKS, PREVENTING DNA REPAIR MECHANISMS

Jesús M. Bañales  et al.

SCAVENGER RECEPTOR MARCO IS ASSOCIATED WITH AN IMMUNOSUPPRESSIVE MICROENVIRONMENT AND TUMOR PROGRESSION IN INTRAHEPATIC CHOLANGIOCARCINOMA
SCAVENGER RECEPTOR MARCO IS ASSOCIATED WITH AN IMMUNOSUPPRESSIVE MICROENVIRONMENT AND TUMOR PROGRESSION IN INTRAHEPATIC CHOLANGIOCARCINOMA

Jesús M. Bañales  et al.

MIR-21-5P DRIVES NASH-ASSOCIATED HEPATOCARCINOGENESIS
MIR-21-5P DRIVES NASH-ASSOCIATED HEPATOCARCINOGENESIS

Jesús M. Bañales  et al.

THERAPEUTIC POTENTIAL OF TARGETING PROTEIN HYPER-SUMOYLATION IN CHOLANGIOCARCINOMA
THERAPEUTIC POTENTIAL OF TARGETING PROTEIN HYPER-SUMOYLATION IN CHOLANGIOCARCINOMA

Jesús M. Bañales  et al.

KLF5 UPREGULATION IS A COMMON EVENT IN CHOLANGIOCARCINOMA, ACTING AS AN ONCOGENE AND CONSTITUTING A BAD PROGNOSTIC FACTOR
KLF5 UPREGULATION IS A COMMON EVENT IN CHOLANGIOCARCINOMA, ACTING AS AN ONCOGENE AND CONSTITUTING A BAD PROGNOSTIC FACTOR

Jesús M. Bañales  et al.

Item 1 - 10 / 10
1